Rosoxacin: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Rosoxacin.svg|Rosoxacin | |||
File:Rosoxacin synthesis.svg|Rosoxacin synthesis | |||
</gallery> | |||
Latest revision as of 01:16, 20 February 2025
Rosoxacin is an antibiotic drug that belongs to the class of quinolone antibiotics. It was discovered in the 1970s and is used in the treatment of bacterial infections.
History[edit]
Rosoxacin was discovered in the 1970s by the pharmaceutical company Eli Lilly. It was one of the first quinolone antibiotics to be developed and has been used in the treatment of various bacterial infections.
Medical uses[edit]
Rosoxacin is used in the treatment of a variety of bacterial infections, including urinary tract infections, respiratory tract infections, and skin infections. It works by inhibiting the DNA gyrase enzyme, which is necessary for the replication of bacterial DNA.
Side effects[edit]
Like all antibiotics, rosoxacin can cause side effects. These can include nausea, vomiting, diarrhea, and rash. In rare cases, it can cause more serious side effects such as anaphylaxis and Clostridium difficile infection.
Mechanism of action[edit]
Rosoxacin works by inhibiting the DNA gyrase enzyme, which is necessary for the replication of bacterial DNA. This prevents the bacteria from reproducing and spreading, allowing the body's immune system to eliminate the infection.
